Cardioprotective agent and a therapeutic agent for ischemic disease comprising n-containing heterocyclic compounds, and a process for the preparation of the same compounds
CA 1317296 C · Owner: Sakamoto, Yoshie · Inventors: Kuno, Atsushi; Maeda, Kazuhiro; Takasugi, Hisashi
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A pharmaceutical composition as a cardioprotective agent or as a therapeutic agent for ischemic disease comprising a compound of the formula:, wherein R1 is lower alkyl substituted with a heterocyclic group; carbamoyl, substituted with heterocyclic(lower)alkyl or with lower alkylamino(lower)alkyl;, N-containing heterocycliccarbonyl optionally substituted with lower alkyl; or ureido substituted with, lower alkylamino(lower)alkyl; and R2 is phenyl substituted with nitro, and X is =N- or , in which R3 is lower alkyl; or, R2 is lower alkyl, and, X is , in which R3 is phenyl substituted with nitro;, or its salt, as an active ingredient in association with, a pharmaceutically acceptable …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Granted May 4, 1993. A Canadian patent filed before October 1, 1989 lasted 17 years from grant, so its term ended May 4, 2010.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.